HYPERBARIC OXYGEN MECHANISMS OF ACTION
In 2017, IPAK will be finishing (with stellar collaborators) an important review of the mechanisms of action of FDA-approved applications of hyperbaric oxygen therapies. We will also study and compare the mechanisms of pathogenesis of numerous FDA-approved and off-label applications of HBOT. Overlap of mechanisms will point to likely fruitful areas of future translational research.
There is a surprisingly diverse number of applications, and a corresponding variety of specific mechanisms of action.
Your support will allow us to finish the major review, which will be submitted to a major translational research journal for publication when completed.